Memorial Healthcare

Memorial Healthcare is an independent, community-owned healthcare system based in Owosso, Michigan, that has established itself as a national leader in neurological research and clinical care. The organization is home to the Memorial Healthcare Institute for Neuroscience, which serves as a high-volume clinical trial site for global pharmaceutical companies, particularly in the fields of Multiple Sclerosis (MS) and migraine. As one of the most active MS research centers in the United States, Memorial Healthcare participates in pivotal Phase 2 and Phase 3 clinical trials for next-generation disease-modifying therapies, including BTK inhibitors and monoclonal antibodies. The system provides a comprehensive range of medical services, including oncology, orthopedics, and emergency care, while maintaining a specialized focus on advancing precision medicine. Its research-driven approach allows patients in a community setting to access cutting-edge treatments often found only at large academic medical centers. Memorial Healthcare is also recognized for its use of advanced neuroimaging and infusion technologies to improve patient outcomes in chronic neurological conditions.